Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01759355 · ClinicalTrials.gov registry record
Hybrid PET/MR in the Therapy of Cervical Cancer
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT01759355 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 18 participants.
The verdict
NCT01759355 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is a two arm, single center feasibility study of 20 patients with non-metastatic cervical cancer managed with surgery and/or chemoradiation therapy at UNC Hospitals. Subjects will undergo PET/MRI scans before, during (chemoradiation group only), and after treatment.
Interventions
- PROCEDURE FDG PET/MR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-10 |
| Est. Completion | 2020-05-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01759355
The ClinicalTrials.gov registry entry for NCT01759355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG PET/MR is the first listed.
NCT01759355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01759355 about?
NCT01759355 is a clinical study titled "Hybrid PET/MR in the Therapy of Cervical Cancer". This is a two arm, single center feasibility study of 20 patients with non-metastatic cervical cancer managed with surgery and/or chemoradiation therapy at UNC Hospitals. Subjects will undergo PET/MRI scans before, during (chemoradiation group only), and after treatment.
What is the current status of trial NCT01759355?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2012-10. Estimated completion is 2020-05-28.
What interventions are being tested in trial NCT01759355?
The interventions under investigation include: FDG PET/MR (PROCEDURE).
Who is sponsoring clinical trial NCT01759355?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.